Search results
Results From The WOW.Com Content Network
The falling share price has pushed the stock's dividend yield to nearly 6%. ... In other words, Pfizer's next growth phase could already be starting. This growth should support the dividend.
A high-yield dividend stock with long-term potential Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% appears unsustainable ...
Whether Pfizer's stock price surges higher now or later, investors are getting a compelling high yield to wait, backed by strong underlying free cash flow. Final thoughts
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
Pfizer's 5.7% dividend yield, while attractive, raises significant sustainability concerns. The company's payout ratio has skyrocketed to 436%, far exceeding the 75% threshold that typically ...
Pfizer's stock price was hammered, but that didn't prevent the company from meeting and raising its dividend commitment. Last December, the pharmaceutical company raised its payout for the 15th ...
For premium support please call: 800-290-4726 more ways to reach us
Pfizer's dividends should keep flowing and growing.